Holen Sie sich die Stockscreener-App
2.27
6.57%
0.14
Schlusskurs vom Vortag:
$2.13
Offen:
$2.12
24-Stunden-Volumen:
206.36K
Relative Volume:
1.32
Marktkapitalisierung:
$23.07M
Einnahmen:
$755.00K
Nettoeinkommen (Verlust:
$-9.33M
KGV:
-0.3975
EPS:
-5.71
Netto-Cashflow:
$-5.43M
1W Leistung:
+2.71%
1M Leistung:
+35.12%
6M Leistung:
-47.82%
1J Leistung:
-42.39%
1-Tages-Spanne:
$2.09
$2.2998
1-Wochen-Bereich:
$2.07
$2.48
52-Wochen-Spanne:
$1.32
$7.659
Mangoceuticals Inc Stock (MGRX) Company Profile
Firmenname
Mangoceuticals Inc
Sektor
Branche
Telefon
(833) 626-4679
Adresse
15110 DALLAS PKWY, SUITE 600, DALLAS
Vergleichen Sie MGRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
2.27 | 23.07M | 755.00K | -9.33M | -5.43M | -5.71 |
|
VEEV
Veeva Systems Inc
|
276.43 | 45.01B | 2.97B | 809.93M | 1.33B | 4.87 |
|
TEM
Tempus Ai Inc
|
86.38 | 13.58B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
71.03 | 12.92B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
92.49 | 7.88B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.36 | 7.06B | 906.14M | -52.62M | 89.62M | -0.3621 |
Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten
Risk vs reward if holding onto Mangoceuticals Inc.2025 Price Targets & Weekly High Momentum Picks - Newser
Short interest data insights for Mangoceuticals Inc.July 2025 Fed Impact & High Yield Equity Trading Tips - Newser
Mangoceuticals Grants Shares and Options to Executives - TipRanks
How to use a screener to detect Mangoceuticals Inc. breakouts2025 Winners & Losers & Real-Time Volume Trigger Notifications - Newser
Analyzing Mangoceuticals Inc. with multi timeframe chartsJuly 2025 Setups & Risk Managed Investment Signals - Newser
Ranking Mangoceuticals Inc. among high performing stocks via toolsPortfolio Gains Summary & Fast Gain Swing Trade Alerts - Newser
Can machine learning forecast Mangoceuticals Inc. recoveryJuly 2025 Action & Long-Term Growth Stock Strategies - Newser
Will Mangoceuticals Inc. stock go up soonWeekly Profit Analysis & High Yield Stock Recommendations - Newser
Price action breakdown for Mangoceuticals Inc.Earnings Miss & Weekly High Conviction Trade Ideas - Newser
Detecting price anomalies in Mangoceuticals Inc. with AIEarnings Overview Summary & Weekly Watchlist for Consistent Profits - Newser
Regression analysis insights on Mangoceuticals Inc. performanceTake Profit & Daily Profit Focused Stock Screening - Newser
Mangoceuticals Inc. stock trend forecastPrice Action & Verified High Yield Trade Plans - Newser
Published on: 2025-09-12 01:30:16 - Newser
Will a bounce in Mangoceuticals Inc. offer an exitDollar Strength & Free High Accuracy Swing Entry Alerts - Newser
Published on: 2025-09-11 06:25:57 - Newser
Mangoceuticals Inc. stock daily chart insightsJuly 2025 Update & Daily Chart Pattern Signals - Newser
Strategies to average down on Mangoceuticals Inc.Quarterly Trade Report & Daily Market Momentum Tracking - Newser
Best data tools to analyze Mangoceuticals Inc. stockGlobal Markets & Real-Time Buy Zone Alerts - Newser
Analyzing drawdowns of Mangoceuticals Inc. with statistical toolsSwing Trade & Daily Stock Trend Reports - Newser
Chart based exit strategy for Mangoceuticals Inc.Jobs Report & Weekly Consistent Profit Watchlists - Newser
What MACD and RSI say about Mangoceuticals Inc.July 2025 Decliners & Community Trade Idea Sharing Platform - Newser
Real time scanner hits for Mangoceuticals Inc. explainedMarket Volume Summary & Long Hold Capital Preservation Tips - Newser
Is Mangoceuticals Inc. showing signs of accumulation2025 Momentum Check & Daily Stock Trend Reports - Newser
What is Mangoceuticals Inc. s revenue forecastPortfolio Value Report & Long-Term Safe Investment Ideas - Lancaster City Council
Is this a good reentry point in Mangoceuticals Inc.2025 Price Action Summary & AI Driven Price Forecasts - Newser
Is Mangoceuticals Inc. stock bottoming outMarket Movement Recap & Safe Entry Momentum Tips - Newser
Mangoceuticals Inc. Tests 50 Day MA After Sharp DeclineJuly 2025 Levels & Verified High Yield Trade Plans - beatles.ru
Finanzdaten der Mangoceuticals Inc-Aktie (MGRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.30%
0.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):